Dr. Gnanasekar Munirathinam, a researcher in the Department of Biomedical Sciences at the University of Illinois College of Medicine at Rockford, has been researching new treatment approaches for prostate cancer for over 10 years. In his laboratory, he investigates the therapeutic potential of several plant products and their derivatives for prostate cancer treatment. He is also interested in screening specific genes in human prostate cancer cells to evaluate approaches to treating prostate cancer.
Dr. Munirathinam joined the College of Medicine at Rockford in 2001 and has made several important discoveries to combat aggressive prostate cancer using naturally occurring compounds in plants. These encouraging results have been published in many scientific journals. He and his team believe that the natural compounds they are working with have great clinical potential for prostate cancer treatment with minimal side effects to patients. However, more research needs to be done to bring these compounds to clinical use. Therefore, they are seeking research funding for their studies.
In addition to prostate cancer research, Dr. Munirathinam serves on the editorial boards for Oncology Letters, Pharmacologia, Journal of Oncology and Biomarkers Research, American Journal of Cancer Biology, American Journal of Clinical Cancer Research, American Journal of Cancer Therapeutics and Pharmacology, and he is an Academic Editor for PLOS ONE. He has also served on the advisory board of RNAi Research and Therapeutics Conferences organized by Global Technology Community. He has received several awards and honors for his research work. Well-published, Dr. Munirathinam received his PhD in Biotechnology at Anna University in Chennai, India, where he also served as a research fellow.